UnitedHealth stock to cut 680 points off the Dow's price after earnings debacle

Dow Jones
04-17

MW UnitedHealth stock to cut 680 points off the Dow's price after earnings debacle

By Tomi Kilgore

The stock is set to suffer its worst day since 1999 after the first quarterly earnings miss in years and the full-year outlook was slashed

Shares of UnitedHealth Group Inc. took a historic dive in early Thursday trading after the health insurer slashed its full-year outlook and missed quarterly expectations for the first time in years, citing increased care activity in its Medicare Advantage business as the first quarter ended.

The stock $(UNH)$ tumbled 18.9% in premarket trading, which puts it on track for its biggest one-day selloff since September 1999.

The implied price decline would cut about 680 points off the Dow Jones Industrial Average's DJIA price.

Dow futures (YM00) were shedding about 393 points, or 1%, while S&P 500 futures (ES00) were rising 0.6%.

The company said it served more people during the first quarter, but the problem was there a lot more people using UnitedHealthcare's Medicare Advantage coverage needed treatment than previously expected.

That "heightened care activity," which was most notable within physician and outpatient services, became visible as the quarter closed.

UnitedHealth now expects 2025 adjusted earnings per share, which excludes nonrecurring items, of $26 to $26.50, down from a previous guidance range of $29.50 to $30.

The company also reported first-quarter adjusted EPS that rose to $7.20 from $6.91 a year ago, but missed the average analyst EPS estimate compiled by FactSet of $7.29.

That was the first quarterly EPS miss in at least five years, based on available FactSet data going back to the first quarter of 2020.

On top of the increased senior care activity, the company said unexpected changes in the profile of members in its Optum Health business hurt planned reimbursements. And there was a greater-than-expected impact to current and new "complex patients" from Medicare funding cuts.

Total revenue for the quarter grew 9.8% to $109.58 billion, but that also missed the FactSet consensus of $111.58 billion.

-Tomi Kilgore

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

April 17, 2025 06:48 ET (10:48 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10